6ThThe Bundesinstitut rejected that application, citing the judgment in Case C-201/94 Smith & Nephewand Primecrown [1996] I-5819. That judgment, the Bundesinstitut argued, establishes that the extension to an imported medicinal product of a marketing authorisation already issued to another medicinal product in the State of importation is subject to the condition that the two medicinal products have a common origin, that is, that their manufacturers are part of the same group of undertakings or, at the very least, that they produce those medicinal products under agreements with the same licensor.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.